Company: TGB
Filing Date: 2025-07-02
Form Type: F-10
Source: 0001062993-25-012433
Chunk: 29

Company: TASEKO MINES LTD
Filing Date: 2025-07-02
Form: F-10
Chunk 29
---
 no pre-emptive or conversion rights.

Warrants

This section describes the general terms that will apply to any Warrants for the purchase of Common Shares. We may issue Warrants independently or together with other securities, and Warrants sold with other securities may be attached to or separate from the other securities. Warrants may be issued directly by us to the purchasers thereof or under one or more warrant indentures or warrant agency agreements to be entered into by us and one or more banks or trust companies acting as warrant agent. Warrants, like other Securities that may be sold, may be listed on a securities exchange subject to exchange listing requirements and applicable legal requirements.

<div align='center'>21</div>

This summary of some of the provisions of the Warrants is not complete. The statements made in the Prospectus relating to any warrant agreement and Warrants to be issued under the Prospectus are summaries of certain anticipated provisions thereof and do not purport to be complete and are subject to, and are qualified in their entirety by reference to, all provisions of the applicable warrant agreement. Investors should refer to the warrant indenture or warrant agency agreement relating to the specific warrants being offered for the complete terms of the Warrants. A copy of any warrant indenture or warrant agency agreement relating to an offering ofWarrants will be filed by us with the applicable securities regulatory authorities in Canada following its execution.

The particular terms of each issue of Warrants will be described in the applicable Prospectus Supplement. This description will include, where applicable:

•the designation and aggregate number of Warrants;

•the price at which the Warrants will be offered;

•the currency or currencies in which the Warrants will be offered;

•the date on which the right to exercise the Warrants will commence and the date on which the right will expire;

•the number of Common Shares that may be purchased upon exercise of each Warrant and the price at which and currency or currencies in which the Common Shares may be purchased upon exercise of each Warrant;

•the designation and terms of any securities with which the Warrants will be offered, if any, and the number of the Warrants that will be offered with each security;

•the date or dates, if any, on or after which the Warrants and the related securities will be transferable separately;

•whether the Warrants will be subject to redemption and, if so, the terms of such redemption provisions;

•whether the Warrants are to be issued in registered form, "book-entry only" form, non-cert